Book a free demo with us
Book Now

Beyond Air

Formerly AIT Therapeutics

Beyond Air, Inc. operates as a medical device and biopharmaceutical company. We are led by a team committed to revolutionizing nitric oxide therapy with the LungFit product family.

Total Fundraised$5B

PE Round
Late Stage
Debt Financing
Pre-IPO
Series C
Series B
Series A
Others
Calendar Image2011
Established
HeadquarterGradient ImageGarden City, New York, United States
Headquarter
OperationalGradient Image
ISR
USA
Operational Market
SectorGradient Image
Biotechnology
Medical
Medical Device
Healthcare
Primary Sector
EmployeeGradient Image11 - 50
Employees
PinGradient ImagePost-IPO Equity
Current Stage
GlobeGradient Imagehttps://www.beyondair.net/
Website

Funding Types by Funds Raised (in USD)

Content Locked

Login or Register a FREE account to continue browsing our content

Cumulative Funding Raised Over Time

Content Locked

Login or Register a FREE account to continue browsing our content

Beyond Air's Investors by Funding Rounds

Funding Round

Announced Date

Disclosed Investors

Round Amount (USD)

Content Locked

Login or Register a FREE account to continue browsing our content

Beyond Air's
Key Team Members

Steve Lisi
Douglas Larson
Frederick Montgomery, PhD
Michael Gaul